Want to see HK:8296 full AI Analyst Report?
Top Page
Sino-Life Group Limited
(8296)
Select Model
Select Model
Rating:48Neutral
Price Target:
HK$0.19
▼(-51.75% Downside)
Action:Reiterated
Date:10/21/26
The score is held down primarily by weak financial performance (persistent losses, recent revenue decline, and negative operating/free cash flow). Technicals provide some offset with short-term momentum, but the extremely overbought RSI and price below the 200DMA add risk. Valuation is also constrained by a negative P/E and no dividend yield data.
Positive Factors
Moderate Leverage
The lower debt-to-equity ratio indicates reduced balance-sheet strain compared with earlier years. Moderate leverage can preserve financial flexibility and reduce obligations that compete with operating investment, although this benefit depends on the company stabilizing losses and cash generation.
Negative Factors
Persistent Net Losses
Recurring net losses indicate that the current business model has not converted revenue and gross profit into sustainable shareholder returns. Continued losses can weaken the equity base over time, constrain reinvestment, and make a durable recovery dependent on meaningful operational improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Moderate Leverage
The lower debt-to-equity ratio indicates reduced balance-sheet strain compared with earlier years. Moderate leverage can preserve financial flexibility and reduce obligations that compete with operating investment, although this benefit depends on the company stabilizing losses and cash generation.
Read all positive factors
Sino-Life Group Limited (8296) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$17.95M
Dividend YieldN/A
Average Volume (3M)8.16K
Price to Earnings (P/E)―
Beta (1Y)-0.22
Revenue Growth-26.00%
EPS Growth-188.55%
CountryHK
Employees134
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)-0.17
Shares Outstanding94,500,000
10 Day Avg. Volume8,400
30 Day Avg. Volume8,160
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)0.23
Price to Sales (P/S)0.43
P/FCF Ratio-4.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sino-Life Group Limited Business Overview & Revenue Model
Company Description
Sino-Life Group Limited, an investment holding company, provides funeral and related services in the People’s Republic of China, Taiwan, Hong Kong, and Vietnam. It operates in two segments, Funeral Services; and Biotechnical and other businesses. ...
Sino-Life Group Limited Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.34M | 64.38M | 74.94M | 72.57M | 77.97M | 72.86M |
| Gross Profit | 14.02M | 30.95M | 32.28M | 33.48M | 39.80M | 37.98M |
| EBITDA | -12.06M | -2.37M | 174.00K | 1.70M | 17.78M | -4.28M |
| Net Income | -16.47M | -6.56M | -8.70M | -7.17M | -847.00K | -9.87M |
Balance Sheet | ||||||
| Total Assets | 207.59M | 229.53M | 250.63M | 271.71M | 284.79M | 263.85M |
| Cash, Cash Equivalents and Short-Term Investments | 127.48M | 133.16M | 148.63M | 173.51M | 180.59M | 156.13M |
| Total Debt | 19.29M | 21.79M | 29.68M | 37.43M | 27.90M | 33.49M |
| Total Liabilities | 121.75M | 131.29M | 147.09M | 163.17M | 153.97M | 158.27M |
| Stockholders Equity | 109.17M | 120.42M | 123.45M | 123.72M | 113.22M | 114.61M |
Cash Flow | ||||||
| Free Cash Flow | -2.91M | -6.22M | -8.97M | -3.04M | 7.77M | -4.31M |
| Operating Cash Flow | -2.91M | -4.85M | -8.21M | -2.60M | 10.24M | -407.00K |
| Investing Cash Flow | 2.77M | 2.08M | -3.30M | 17.36M | -32.20M | -1.83M |
| Financing Cash Flow | -2.09M | -7.40M | -2.10M | -7.66M | 18.77M | -7.75M |
Sino-Life Group Limited Technical Analysis
Neutral
0.40
Price Trends
0.16
Positive
0.17
Positive
0.25
Negative
Market Momentum
0.01
Negative
72.09
Negative
86.11
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8296, the sentiment is Neutral. The current price of 0.4 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.16, and above the 200-day MA of 0.25, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 72.09 is Negative, neither overbought nor oversold. The STOCH value of 86.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8296.
Sino-Life Group Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.44B | 8.08 | 43.78% | 12.65% | -14.68% | -13.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | HK$6.03B | 14.01 | 6.50% | 20.98% | ― | ― | |
52 Neutral | HK$1.75B | 48.06 | 6.47% | ― | 2.78% | -41.23% | |
51 Neutral | HK$213.25M | -1.84 | -13.22% | 16.67% | -16.99% | -326.96% | |
50 Neutral | HK$67.84M | -37.50 | -0.93% | 6.43% | -2.31% | 66.07% | |
48 Neutral | HK$17.95M | -0.76 | -17.95% | ― | -26.00% | -188.55% |
* Consumer Cyclical Sector Average
HK:8296
Sino-Life Group Limited
0.19
-0.21
-52.50%
HK:1448
Fu Shou Yuan International Group
2.64
-0.23
-8.08%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
<0.01
4.17%
HK:0922
Anxian Yuan China Holdings Limited
0.09
-0.06
-37.33%
HK:1830
Perfect Medical Health Management Limited
1.14
-0.10
-8.14%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.93
0.50
115.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.